NCT03946358 Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL) Status COMPLETED Phase PHASE2
NCT03935204 Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) Status COMPLETED Phase PHASE2
NCT03912415 Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer (FERMATA) Status UNKNOWN Phase PHASE3
NCT03912402 Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA) Status UNKNOWN Phase PHASE2
NCT03894215 RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer Status TERMINATED Phase PHASE2
NCT03885505 An Analysis of the Quality of Life and Sexual Quality of Life of Cervical Cancer Radiotherapy Patients Status UNKNOWN Phase N/A
NCT03876860 An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis Status RECRUITING Phase NA
NCT03873376 Self-sampling Among Long-term Non-attenders to Cervical Cancer Screening Status COMPLETED Phase NA
NCT03872635 Effects of Anesthesia on Tumor Immunity and Insulin Resistance During Perioperative Period Status COMPLETED Phase NA
NCT03856684 Evaluation of Three Strategies Based on Vaginal Self-sampling Kit Send to Home of Unscreened Women for Cervical Cancer Status COMPLETED Phase NA
NCT03856437 A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination Status COMPLETED Phase NA
NCT03853915 FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II) Status RECRUITING Phase NA
NCT03852979 Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility Status TERMINATED Phase PHASE2
NCT03852823 Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours Status UNKNOWN Phase PHASE1
NCT03841110 FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03833479 TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation Status ACTIVE_NOT_RECRUITING Phase PHASE2